Botanic Choice
Kava Kava Extract 50 mg
Brand context
Catalog
253
products
With avoid flag
2
products
FDA recalls
0
history
CAERS
13
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
5
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category A
- Kava kavaCategory A
LiverTox Category A (well-established cause). Severe idiosyncratic hepatitis including liver failure / transplant. Banned or restricted in Germany, UK, France, Switzerland.
LiverTox →
Supplement Facts
3 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Calcium mineralUNII · SY7Q814VUP UL · set6 effects | 127 mg | 13% |
| Phosphorus mineralUNII · 27YLU75U4W UL · set2 effects | 98 mg | 10% |
| Kava Kava extract Kava kavaherb LiverTox A | 50 mg | — |
What this product supports · authorized claims
6 authority-backed effects
Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.
- from: Calcium · Phosphorus
- from: Calcium
- from: Calcium
- from: Calcium · Phosphorus
- from: Calcium
- from: Calcium
FDA CAERS · adverse event context
5
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Microcrystalline Cellulose · Stearic Acid · Croscarmellose Sodium · Magnesium Stearate · Aqueous Film Coating
Chemically equivalent
Same formula, different brand
Products with identical sorted (ingredient, amount) tuples.